Valproic Acid Enhances the Anti-tumor Effect of Pegylated Interferon-α Towards Pancreatic Cancer Cell Lines

被引：0
|
作者：
Sugimoto, Koji [1 ]
Shimada, Mitsuo [1 ]
Utsunomiya, Toru [1 ]
Morine, Yuji [1 ]
Imura, Satoru [1 ]
Ikemoto, Tetsuya [1 ]
Iwahashi, Shuichi [1 ]
机构：
[1] Univ Tokushima, Dept Surg, Inst Hlth Biosci, Tokushima 7708503, Japan
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 07期
关键词：
Histone deacetylase inhibitor; valproic acid; pegylated interferon-alpha; pancreatic cancer; HISTONE DEACETYLASE INHIBITORS; REGULATORY FACTOR-8; IN-VITRO; COMBINATION THERAPY; IFN-ALPHA; EXPRESSION; APOPTOSIS; ANGIOGENESIS; REGRESSION; CARCINOMA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Valproic acid (VPA) acts as a specific inhibitor of class I HDACs and it use has been proven to be safe since a long time. Materials and Methods: In the present study, we investigated the effect of VPA in the combination with pegylated interferon-alpha (PEG-IFN alpha) in inhibition of cell proliferation of human pancreatic cancer cell lines. Results: VPA enhanced the effect of PEG-IFNa, and the effect was decreased by the caspase inhibitor. VPA alone and VPA in combination with PEG-IFNa increased the expression of interferon-alpha receptor and interferon regulatory factor 8. Conclusion: The combination of VPA and PEG-IFN alpha can be useful for the treatment of pancreatic cancer.
引用
收藏
页码：3403 / 3409
页数：7
相关论文
共 50 条
  • [31] Commentary: Anti-tumor Effect of Oleic Acid in Hepatocellular Carcinoma Cell Lines via Autophagy Reduction
    Lin, Jiong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [32] mTOR inhibitor enhances anti-tumor effect of BET bromodomain inhibitor in small cell lung cancer
    Kumari, Anju
    Gesumaria, Lisa
    Fetsch, Patricia
    Miettinen, Markku
    Hughitt, Keith
    Mock, Beverly
    Thomas, Craig
    Schrump, David S.
    Chen, Haobin
    CANCER RESEARCH, 2020, 80 (16)
  • [33] Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells
    He, Meng
    Liao, Qiuyu
    Liu, Dong
    Dai, Xufang
    Shan, Meihua
    Yang, Mingzhen
    Zhang, Yang
    Zhai, Liuyue
    Chen, Lingxi
    Xiang, Li
    He, Mei
    Li, Shuhui
    Chen, An
    Sun, Liangbo
    Lian, Jiqin
    BIOCHEMICAL PHARMACOLOGY, 2023, 211
  • [34] Mycoplasma infection of cancer cells enhances anti-tumor effect of oxidized methylcytidines
    Pang, Guo-Zheng
    Zhao, Ya-Hui
    Wang, Yuan-Xian
    Rong, Shao-Qin
    Gao, Hai
    Zhou, Dan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 672 : 193 - 200
  • [35] Chromosome Missegregation Triggers Tumor Cell Pyroptosis and Enhances Anti-Tumor Immunotherapy in Colorectal Cancer
    Duan, Wei
    Hosea, Rendy
    Wang, Lingxian
    Ruan, Cao
    Zhao, Fuqiang
    Liu, Jingyi
    Zhao, Hezhao
    Miyagishi, Makoto
    Wu, Shourong
    Kasim, Vivi
    ADVANCED SCIENCE, 2025,
  • [36] Anti-tumor effect of selective progesterone receptor modulator (ulipristal acetate) on endometrial cancer cell lines
    Lee, Ha-Young
    Ko, A. Ra
    Kang, Dong-Woo
    Kim, Yu-Seon
    Kim, Su-Min
    Kang, Tae-Wook
    Lee, Shin-Wha
    Kim, Yong-Man
    CANCER RESEARCH, 2016, 76
  • [37] CCR2 Blockade Enhances Anti-tumor Immune Responses in Patients with Pancreatic Cancer
    Sanford, D.
    Belt, B.
    Panni, R.
    Nywening, T.
    Wang-Gillam, A.
    Goedegebuure, P.
    Linehan, D.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S39 - S39
  • [38] Investigating the anti-tumor effect of Chalcone derivatives on pancreatic cancer, and its mechanism to induce cell death
    Huang, Cheng-Hung
    Hsu, Sheng-Kai
    Chiu, Chien-Chih
    Tseng, Chih-Hua
    CANCER SCIENCE, 2025, 116 : 404 - 404
  • [39] Temporary blockade of interferon-γ ameliorates doxorubicin-induced cardiotoxicity without influencing the anti-tumor effect
    Ma, Pan
    Qin, Yue
    Cao, Hong
    Erben, Ulrike
    Ni, Chen
    Qin, Zhihai
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [40] Vitamin K2 has growth inhibition effect against hepatocellular carcinoma cell lines but does not enhance anti-tumor effect of combination treatment of interferon-α and fluorouracil in vitro
    Nakamura, Masato
    Nagano, Hiroaki
    Noda, Takehiro
    Wada, Hiroshi
    Ota, Hideo
    Damdinsuren, Bazarragchaa
    Marubashi, Shigeru
    Miyamoto, Atsushi
    Takeda, Yutaka
    Doki, Yuichiro
    Umeshita, Koji
    Dono, Keizo
    Sakon, Masato
    Monden, Morito
    HEPATOLOGY RESEARCH, 2006, 35 (04) : 289 - 295
12345